Role and Indications of Primary Total Hip Arthroplasty at the Cheikh Ahmadoul Khadim National Hospital Center of Touba

Abstract

This retrospective descriptive study reports the activity and indications for primary total hip arthroplasty (THA) over a 20-month period in a newly established non-university hospital in Touba, Senegal. Among the 70 primary THAs included, femoral neck fractures and primary osteoarthritis were the main indications, with traumatic etiologies and their sequelae accounting for more than half of the cases. The authors believe that decentralized THA management is feasible with appropriate staff, infrastructure, and implants.

Share and Cite:

Dione, A. , Djiba, C. , Diagne, M. , Dembélé, B. , Dieye, N. and Diémé, C. (2026) Role and Indications of Primary Total Hip Arthroplasty at the Cheikh Ahmadoul Khadim National Hospital Center of Touba. Open Journal of Orthopedics, 16, 108-115. doi: 10.4236/ojo.2026.163012.

1. Introduction

Total hip arthroplasty is a surgical procedure to replace a diseased hip joint with a mechanical prosthesis; the goal is to restore the joint’s functional integrity. It is called primary or first-line surgery when it is performed for the first time. Revision surgery is the replacement of all or part of a primary arthroplasty due to complications.

In developed countries, primary total hip arthroplasty is one of the most common procedures [1] [2]. In 2007, it was considered the surgery of the 20th century due to the large number of hip replacements performed and the significant and notable improvement in the quality of life of the patients who underwent it [3].

In sub-Saharan African regions, with the exception of South Africa, this surgery is not common [4] despite the increase and improvement of hospital infrastructure [5]. In Senegal, it began tentatively in the capital, Dakar, at the University Hospital Center (CHU) in 1980 [6] and remains largely performed in that city. This study was conducted in Touba, a city located 200 km from the capital. Its objective was to determine the role of primary total hip arthroplasty and its indications.

2. Patients and Methods

This was a descriptive, retrospective, observational, cross-sectional study conducted over a 20-month period (September 19, 2022 - April 5, 2024) in the orthopedics and traumatology department of the Touba University Hospital. This is a new hospital facility that began operations in May 2022.

The department has a local medical and paramedical team, including two orthopedic surgeons, 12 inpatient beds, and an operating room exclusively dedicated to aseptic surgery of the musculoskeletal system.

All patients who underwent total hip arthroplasty were included in the study. Patients who underwent revision total hip arthroplasty were excluded. The prostheses used were uncemented with a polyethylene-metal bearing surface. The surgical approach was posterolateral. A total of 70 patients were identified. The mean age was 53 years, ranging from 18 to 81 years, distributed as follows:

  • 18 - 24 years: 3 patients

  • 25 - 44 years: 19 patients

  • 45 - 64 years: 28 patients

  • 65 years and older: 20 patients

There were 38 female and 32 male patients, for a sex ratio of 0.84. The majority of patients resided in the Touba region and its immediate surroundings (81.42%).

In terms of employment, 75% worked in the informal sector without any health insurance.

Comorbidities were observed in 23 patients (27.14%), including 9 cases of hypertension, 9 cases of sickle cell disease, and 5 cases of diabetes.

The role of primary total hip arthroplasty was determined by considering the total number of surgical procedures performed in the orthopedic trauma department and those involving the femoroacetabular joint.

Indications were determined based on clinical and Para clinical data from patient records: medical history, physical examination, medical imaging, and laboratory results. These indications were correlated with or related to age, sex, gait status prior to surgery, and any observed comorbidities.

3. Results

1) Role of Total Hip Arthroplasty

During the study period, 655 surgical procedures were performed in the orthopedic and traumatology department, 122 of which involved the hip joint. Table 1 shows the role of primary total hip arthroplasty.

Primary THAs account for 57.3% of hip surgeries.

Table 1. Role of primary total hip arthroplasty.

Intervention

Number

Percentage (%)

Surgical interventions in the department

655

Hip surgeries

122

18.63

Total Hip Arthroplasty (THA)

75

11.45

Primary THAs

70

10.69

Secondary THAs

5

0.76

2) Indications

Table 2 shows the different indications for arthroplasty.

Table 2. Different indications for arthroplasty.

Indication

Number

Percentage (%)

Femoral neck fractures

31

44.2

Primary coxarthrosis

21

30

Femoral head osteomyelitis

9

12.8

Femoral neck nonunion

6

8.5

Femoral neck tumor

2

2.8

Post-traumatic coxarthrosis

1

1.4

Total

70

100

Overall, traumatic causes and their sequelae were observed in 38 patients (54.2%).

Post-traumatic coxarthrosis was secondary to a hip fracture-dislocation.

Table 3 shows the indications for arthroplasty correlated with age groups.

Table 3. Indications for arthroplasty correlated with age groups.

Indication

Age 18 - 24

Age 25 - 44

Age 45 - 65

Age > 65

Total

Femoral neck fractures

0 (0%)

1 (3.1%)

19 (59.4%)

12 (37.5%)

31

Primary coxarthrosis

2 (9.5%)

5 (23.8%)

10 (47.6%)

4 (19.0%)

21

Femoral head osteonecrosis

1 (11.1%)

5 (55.6%)

2 (22.2%)

1 (11.1%)

9

Femoral neck nonunion

0 (0%)

0 (0%)

2 (33.3%)

4 (66.7%)

6

Femoral neck tumor

0 (0%)

2 (100%)

0 (0%)

0 (0%)

2

Post-traumatic coxarthrosis

0 (0%)

0 (0%)

1 (100%)

0 (0%)

1

Total

3

13

34

21

70

The average age for the femoral neck fracture was 60.9 years; 47.3 years for the coxarthrosis; 39 years for the osteonecrosis of the femoral head; 66.3 years for the pseudarthrosis of the femoral neck and 30.5 years for the 2 tumors.

Table 4 represents the indications reported by gender.

Table 5 represents the indications correlated with the observed comorbidities.

Table 6 represents the indications reported to the status of walking before surgery.

Table 4. Indications reported by gender.

Indication

Sex

Number

Percentage (%)

Femoral neck fracture

M

14

20.0

Femoral neck fracture

F

17

24.2

Primary coxarthrosis

M

8

11.4

Primary coxarthrosis

F

13

18.5

Femoral head osteonecrosis

M

5

7.1

Femoral head osteonecrosis

F

4

5.7

Femoral neck nonunion

M

3

4.2

Femoral neck nonunion

F

3

4.2

Femoral neck tumor

M

1

1.4

Femoral neck tumor

F

1

1.4

Post-traumatic coxarthrosis

M

1

1.4

Total M

32

45.7

Total F

38

54.3

Total

70

100

Table 5. The indications correlated with the observed comorbidities.

Indications

Comorbidities

Number

Femoral neck fracture

High blood pressure

9

Diabete

5

Femoral head osteonecrosis

sickle cell disease

9

Table 6. The indications reported to the status of walking before surgery.

Indication

Preoperative Walking Status

Number

Percentage (%)

Femoral neck fracture

Independent walking

31

44.3

Primary coxarthrosis

Limping while walking

19

27.1

Femoral head osteonecrosis

Limping while walking

9

12.9

Femoral neck nonunion

Limping while walking

6

8.6

Femoral neck tumor

Limping while walking

2

2.9

Post-traumatic coxarthrosis

Limping while walking

1

1.4

Total

70

100

4. Discussion

Apart from South Africa, total hip arthroplasty (THA) is not a sustained and widespread practice in other countries of the continent [4] [7] [8]. Yet the indications exist: primary or secondary osteoarthritis of the hip, osteonecrosis of the femoral head, femoral neck fractures, and traumatic or infectious sequelae of the hip joint [9] [10]. This situation is explained by the high cost of this surgical procedure, particularly the prosthetic implant, the frequent shortage of qualified personnel, and the lack of suitable technical facilities. Added to this is the almost complete absence of health insurance systems that could cover the financial burden of this type of surgery [11]. Furthermore, THA is most often performed in university hospitals in major urban centers, sometimes in partnership with surgical teams from European or American countries. All these considerations help explain the scarcity of publications on THA in sub-Saharan Africa. The series are generally short; when they reach the hundred cases it is over fairly long study periods [12]-[23].

Our study is distinguished by two particular features. The first shows that the total hip replacement (THR) was performed in a non-university hospital outside the capital. The second describes a number of cases approaching one hundred in twenty months of operation, ranking first among hip surgeries, despite the department ranking only tenth in surgical procedures. The hospital’s recent opening cannot alone explain these results. The presence of a competent local team (orthopedic surgeons, anesthesiologists, nurses, physiotherapists) and an operating room with complete basic instrumentation dedicated exclusively to musculoskeletal surgery are factors to consider. The other point to emphasize is the current continuous availability of prosthetic implants in Senegal.

In this series, the indications were dominated by trauma, with femoral neck fracture and its progressive complication, nonunion, being the most common. The nonunion resulted from traditional medicine treatment of the fracture. This practice is very frequent in Africa [24]. Epidemiologically, the classic data for a femoral neck fracture are observed: a female predominance, primarily affecting patients aged 60 and over. Femoral neck fractures are becoming increasingly common among the elderly in Africa, with a marked increase in frequency [25]. The choice of total hip arthroplasty (THA) was guided by the low presence of comorbidities and the notable absence of impaired walking ability prior to the fracture. Furthermore, another economic factor facilitated the choice. In Senegal, patients aged 60 and over are exempt from medical expenses, except for prosthesis components, through a health insurance system called the Sesame Plan [26]. In the case of coxarthrosis, it was primary in the majority of cases.

It is the second most common indication. These are lesions observed in young patients at a very advanced stage, with significant functional impairment due to delayed treatment. This delay is due to the exorbitant cost of surgery in patients who are often impoverished and lack any social assistance. The consequence is a difficult total hip replacement (THR). In the vast majority of African publications, coxarthrosis followed by osteonecrosis of the femoral head is the first-line treatment, according to Davies’ meta-analysis [4], unlike our study. However, they share the same characteristics in terms of age and lesion stage. In our patients, osteonecrosis is linked to sickle cell disease type SS. This is a monogenic, autosomal recessive, multisystemic disease characterized by the presence of abnormal hemoglobin (HbS), caused by a single mutation in the beta-globin gene. It is very common in Africa [27]. Among its osteoarticular complications, osteonecrosis of the femoral head is most often encountered on the continent at an advanced stage requiring treatment with a total hip arthroplasty [28].

Total hip arthroplasty (THA) is becoming a reality in sub-Saharan Africa. It is already important to establish national registries to record this joint replacement surgery [4] [7] [29] [30]. This will help address the need for revision surgery, often due to the young age of the patients and implant wear over time.

5. Conclusion

Total hip arthroplasty presents a therapeutic challenge in Africa. Its indications exist and are varied. It can be performed in any hospital. However, it is demanding in terms of equipment, qualified personnel, and accessibility through the establishment of a health insurance system. All these conditions should allow for continuous and controlled activity.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Hernigou, P. (2018) Les prothèses totales de hanche. Bulletin de lAcadémie Nationale de Médecine, 202, 1063-1070.[CrossRef]
[2] Koulischer, S., Jennart, H. and Zorman, D. (2017) L’arthroplastie totale de hanche: Histoire et perspectives d’une intervention chirurgicale emblématique. Revue Medicale de Bruxelles, 38, 181-185.
[3] Learmonth, I.D., Young, C. and Rorabeck, C. (2007) The Operation of the Century: Total Hip Replacement. The Lancet, 370, 1508-1519.[CrossRef] [PubMed]
[4] Davies, P.S., Graham, S.M., Maqungo, S. and Harrison, W.J. (2019) Total Joint Replacement in Sub-Saharan Africa: A Systematic Review. Tropical Doctor, 49, 120-128.[CrossRef] [PubMed]
[5] Lisenda, L., Mokete, L., Nwokeyi, K., Gureja, Y.P. and Lukhele, M. (2018) Development of a Lower Limb Arthroplasty Service in a Developing Country: Lessons Learned after the First 100 Cases (Joints). Acta Orthopaedica Belgica, 82, 570-578.
[6] Diop, E.H.I., Sèye, S.I.L., Bassène, N., Diouf, S., Camara, S. and Pouye, I. (1984) Introduction à l’arthroplastie totale de hanche. Résultats des dix premiers cas dakarois. Dakar Médical, 20, 3-4.
[7] Mulimba, J.A.O. (2007) Is Hip Arthroplasty Viable in a Developing African Country? East and Central African Journal of Surgery, 12, 30-32.
[8] Berenger, T.B., Cédric, D.M., Lionel, K., Gaspary, F., Chiffen, U., Mbuku, R.B., et al. (2025) Challenges of Total Hip Replacement Surgery in Austere Settings: A Case Series of 158 Patients Operated in the Far North Region of Cameroon. Pan African Medical Journal, 50, Article No. 66.[CrossRef] [PubMed]
[9] Geldenhuys, D.B., Cakic, J.N., Mokete, L., Sikhauli, N. and Pietrzak, J.R.T. (2025) An Increased Incidence of Avascular Necrosis as the Predisposing Aetiology for Primary Total Hip Arthroplasty in Sub-Saharan Africa—A Retrospective Review of 1,400 Consecutive Patients. SICOT-J, 11, Article No. 54.[CrossRef]
[10] Tamou Sambo, B. (2017) Total Hip Arthroplasty in a Developing Country: Epidemiological, Clinical and Etiological Aspects and Indications. Journal of Surgery, 5, 130-133.[CrossRef]
[11] Degroote, S., Ridde, V. and De Allegri, M. (2019) Health Insurance in Sub-Saharan Africa: A Scoping Review of the Methods Used to Evaluate Its Impact. Applied Health Economics and Health Policy, 18, 825-840.[CrossRef] [PubMed]
[12] Soulama, M., Diallo, M., Kangoyé, R., et al. (2021) Arthroplasties totales de hanche dans un pays à ressources limitées: Évaluation des résultats à moyen terme. Mali Medical, 36, 23-27.
[13] Ayouba, G., Kombate, N.K., Bakriga, B., et al. (2021) Caractéristiques cliniques, thérapeutiques et évolutives des patients opérés par prothèse totale de hanche à double mobilité au Togo: Étude multicentrique à propos de 147 cas. Health Sciences and Diseases, 22, 5-10.
[14] Ibrahima, F., Fokam, P., Ngongang, F.O. and Esiéné, A. (2014) Résultats préliminaires des prothèses totales de hanche réalisées dans un pays africain à ressources limitées. Revue de Chirurgie Orthopédique et Traumatologique, 100, 264-268.[CrossRef]
[15] Bombah, F., Nguiabanda, L., Diawara, Guemse, E.M. and Mikiela, A. (2023) Arthroplastie totale de hanche: Épidémiologie, technique et résultats de sept ans de pratique à Libreville. Health Sciences and Diseases, 24, 49-53.
[16] Sangwa, M.C., Yuma, Y., Mbaya, D. and Muganza, A. (2023) Arthroplasties hanche et genou dans un milieu à ressource limitée: Expérience innovante de Medpark Clinic. Revue Africaine de Médecine et de Santé Publique, 79-80.
https://www.rams-journal.com/index.php/RAMS/article/view/231
[17] Rohimpitiavana, H.A., Rantoanina, A., Ratsimandresy, D.A., et al. (2016) Résultats de 10 ans d’expérience de pose de prothèse totale de hanche. Revue de Chirurgie Orthopédique et de Traumatologie Malgache, 6, 329-342.
https://www.facmedtananarive.org/pdf/somcot/volume6/1-16.4.somcot.Res-PTH.pdf
[18] Barro, V., Carbonell-Rosell, C., Ribera, J., Villalonga, A., Martin-Domínguez, L., Soza, D., et al. (2025) Challenges in Implementing a Total Hip Arthroplasty Program in a Developing Country: Our Experience at Monkole Hospital in the Democratic Republic of Congo. Revista Española de Cirugía Ortopédica y Traumatología, 69, T254-T259.[CrossRef] [PubMed]
[19] Bimer, G.A., Hailu, S., Wamisho, B.L. and Alemayehu, G. (2024) Patient Self-Reported Functional Outcomes after Total Hip Arthroplasty: Insights from a Tertiary Hospital in Ethiopia. Ethiopian Medical Journal, 62, 127-132.
[20] Fonkoué, L., Kennedy, M.O., Ngongang, O.F., et al. (2024) Cementless Total Hip Arthroplasty at Yaoundé: Indications and Outcome. Health Sciences and Diseases, 25, 143-148.
[21] Essomba, R., Mondji, S., Mbonda, A.N., Tochie, J.N., Abogo, S., Lekina, F., et al. (2022) An 8-Year Audit of the Clinical Profile, Surgical Indications and Therapeutic Outcomes of Total Hip Arthroplasty in a Sub-Saharan Africa Setting: A Retrospective Cohort Study. Journal of Xiangya Medicine, 7, Article No. 6.[CrossRef]
[22] Dossche, L., Noyez, J.F., Ouedraogo, W. and Kalmogho, E. (2014) Establishment of a Hip Replacement Project in a District Hospital in Burkina Faso. The Bone & Joint Journal, 96, 177-180.[CrossRef] [PubMed]
[23] Uwatoronye, N.C., Ego, A.U. and Amaechi, K.U. (2012) Total Hip Replacement in Nigeria: A Preliminary Report. Kuwait Medical Journal, 44, 291-296.
[24] Askew, M.R., Hinchman, C., Rayel, I.M., Jenkins, P., Dada, A., Diallo, M., et al. (2024) The Continued Role of Traditional Bonesetters in East and West Africa: An Expert Consensus Statement. East and Central African Journal of Surgery, 28, 4-9.[CrossRef]
[25] Maria, E. and Amoako-Adjei, O. (2025) A Comprehensive Review of Hip Fractures in Sub-Saharan Africa: Contextual Challenges, Outcomes, and Pathways to Improved Care. Cureus, 17, e97653.[CrossRef]
[26] Taverne, B., Laborde-Balen, G., Rassoul Top, B., Sow, K. and Coumé, M. (2023) Perceptions et utilisation de la couverture maladie universelle (Plan Sésame) par les personnes âgées à Dakar (Sénégal), impacts sur les dépenses de santé liées au diabète et à l’hypertension. Medecine Tropicale et Sante Internationale, 3, 19.
[27] Williams, T.N. (2016) Sickle Cell Disease in Sub-Saharan Africa. Hematology/Oncology Clinics of North America, 30, 343-358.[CrossRef] [PubMed]
[28] Sene, M., Dansoko, A., Ndiaye, A., et al. (2006) Arthroplastie totale de hanche dans l’ostéonécrose aseptique du drépanocytaire au Sénégal: Série de 48 prothèses. Médecine Tropicale, 69, 573-576.
[29] George, A. and Ofori-Atta, P. (2019) Joint Replacement Surgery in Ghana (West Africa)—An Observational Study. International Orthopaedics, 43, 1041-1047.[CrossRef] [PubMed]
[30] Graham, S.M., Howard, N., Moffat, C., Lubega, N., Mkandawire, N. and Harrison, W.J. (2019) Total Hip Arthroplasty in a Low-Income Country: Ten-Year Outcomes from the National Joint Registry of the Malawi Orthopaedic Association. JBJS Open Access, 4, e0027.[CrossRef] [PubMed]

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.